← SynDRA
OLEOYL DOPAMINE
SynDRA canonical compound SYN0007843 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GPR119 |
| Mechanism of action | TRPV agonist |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- ALOX15B
- MAPT
- MPHOSPH8
- MTOR
- NFE2L2
- NFKB1
- NPC1
- NPSR1
- OPRM1
- PIN1
- PLK1
- PMP22
- POLB
- POLH
- POLI
- POLK
- PTH1R
- RAB9A
- RAPGEF3
- RGS4
- SIRT5
- SMAD3
- SMN1
- SNCA
- TARDBP
- TDP1
- THPO
- TP53
- USP1
- USP2
- MAPK1
- LMNA
- KDM4E
- DRD3
- APEX1
- APP
- ARSA
- ATAD5
- ATXN2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM5
- ADA10
- PPP5C
- PPP1CA
- PAFA
- NR5A2
- NCOA3
- LOX15
- LOX12
- IDHC
- HS90B
- HS90A
- GP119
- DRD2
- CP3A4
- CP2CJ
- CP2C9
- CP1A2
- COT2
- CFTR
- BCL2L11
- BAP1
- B2L11
- ALOX12
- ADA17
- PRIO
Cross-references
Synonyms
- N-Oleoyl dopamine
- N-Oleoyldopamine
- OLDA
- UNII-T87P7X9XSZ
- T87P7X9XSZ
- N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-octadecenamide
- CHEMBL250711
- CHEBI:31883
- (Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]octadec-9-enamide
- SR-01000076132
- AC1NQZHH
- Lopac-O-2139
- Lopac0_001058
- SCHEMBL93916
- MLS002153451
- N-(9Z-octadecanoyl)-dopamine
- GTPL5552
- BML3-G02
- cid_5282106
- (9Z)- N-(2-(3,4-Dihydroxyphenyl)ethyl)-9-octadecenamide
- MolPort-003-959-070
- QQBPLXNESPTPNU-KTKRTIGZSA-N
- HMS3648E03
- HMS3263C18
- N-oleoyl-dopamine
- N-Oleoyldopamine (OLDA)
- HMS2232C14
- HMS3412N21
- HMS3676N21
- ZINC8035014
- Tox21_501058
- BDBM50215899
- LMFA08020140
- AKOS024456721
- CCG-205135
- LP01058
- SDCCGSBI-0051028.P002
- NCGC00015765-01
- NCGC00015765-02
Look up OLEOYL DOPAMINE in the interactive SynDRA portal →